Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety and Efficacy of S-606001 in Late-onset Pompe Disease
NCT07750990Phase 2Not yet recruiting
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Nov 2026
- Primary completion
- Aug 2028
01
Overview
Phase 2 trial, sponsored by Shionogi & Co., Ltd. Planned start Nov 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07750990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07750990.